Because valuations are more than just earnings for a particular year.
It's a pretty much derisked assets that is unlikely to require more debt or dilution, has in flight growth initiatives. It's the best placed when Lithium prices turn.
NPAT will be less than $750M but even if it was that applying 8x P/E would mean it was worth $6B, so $8B isn't far off is it?
- Forums
- ASX - By Stock
- Good News & Bad News
Because valuations are more than just earnings for a particular...
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.14 |
Change
-0.050(1.57%) |
Mkt cap ! $9.395B |
Open | High | Low | Value | Volume |
$3.17 | $3.19 | $3.12 | $11.61M | 3.708M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 13300 | $3.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.15 | 144388 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 16224 | 3.140 |
32 | 157891 | 3.130 |
25 | 280978 | 3.120 |
16 | 246952 | 3.110 |
19 | 74842 | 3.100 |
Price($) | Vol. | No. |
---|---|---|
3.150 | 144378 | 27 |
3.160 | 35217 | 11 |
3.170 | 34107 | 8 |
3.180 | 95730 | 10 |
3.190 | 104296 | 14 |
Last trade - 11.58am 15/11/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online